Singapore founded start-up EyRIS demonstrates their deep tech tools in automated image analysis of eye disease.
EyRIS, is making use of a deep learning system which is able to reduce the time to screen retinal images for a number of common eye diseases especially for diabetic patients. These eye diseases include, diabetic retinopathy, glaucoma and age-related macular degeneration.
The deep learning system developed by the Singapore Eye Research Institute and National University of Singapore, automatically screens retinal photographs for signs of diabetic eye diseases, eliminating the time-consuming task of reading these eye scans. This cuts the turnaround time for an eye exam result to be produced within three minutes instead of one hour. The technology is also expected to reduce public health care cost while maintaining standard of care.
“In Singapore there are about 600,000 diabetic patients, it would be time consuming and draining on resources to conduct a national eye screening program for all the patients with the current infrastructure. The deep learning system fits Singapore very well and in some ways, we are transforming healthcare in Singapore. With limited resources the turnaround time could be a few days, but with this system the turnaround time can even be instantaneous.” Explains Mr Lai Teik Kin, Founding CEO of EyRis, Singapore.
“Currently, diabetic patients need to see a doctor on a regular basis to screen for diabetic retinopathy. EyRIS allows improved accessibility of screening and at lower cost.” Said Professor Wong Tien Yin, Medical Director at the Singapore National Eye Centre and one of the founders of EyRIS.
Professor Wong also highlights the need for multiple demonstrations to encourage doctors to take on such technology and in a way showing them that it is at least comparable to a well-trained doctor.
At the recent Singapore Biodesign Thought Leaders Series in October 2019, with theme this year focused on “Ophthalmic Innovations for Asia”, EyRIS showcased their ground-breaking artificial intelligence tool used to screen retinal images. During the Thought Leaders Series both Mr Lai and Professor Wong shared their experiences and concepts on the topic of “Ophthalmic Innovation and Implementation for Asia” together with other panellists. [APBN]